Investing Profile

Margarita Chavez

VC
Managing Director, AbbVie Ventures at AbbVie
Photo of Margarita Chavez, Managing Director at AbbVie Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Katapult Accelerator Network
1378 CONNECTIONS
Katapult Accelerator Network
1378 CONNECTIONS
Katapult Accelerator Network
1378 CONNECTIONS
Arthur Andersen Network
52 CONNECTIONS
Arthur Andersen Network
52 CONNECTIONS
cb
AbbVie Ventures Managing Director
11

Sign in to see all 4 investments on record.

Sign in with Google →
Director, Ventures & Early Stage Collaborations Katapult AcceleratorPresent
Board Member The Afri-CAN CharityPresent
Board Member Katapult AcceleratorPresent
Board Advisor Newron Pharmaceuticals SpAPresent
Chairperson Xylo BioPresent
Venture Partner The Afri-CAN CharityPresent
Venture Partner Katapult AcceleratorPresent
Senior Counsel AbbottPresent
Director, Global Licensing and New Business Development AbbottPresent
Director, Venture Investments, Abbott Biotech Ventures AbbottPresent
Director, Ventures & Early Stage Collaborations Arthur AndersenPresent
Managing Director, AbbVie Ventures AbbViePresent
Board Observer Morphic TherapeuticPresent
Board Member Morphic TherapeuticPresent
Board Member New England Venture Capital AssociationPresent
Board Member Carisma TherapeuticsPresent
Board Observer Jnana TherapeuticsPresent
Board Member Jnana TherapeuticsPresent
Board Member Magnolia NeurosciencesPresent
Board Member Arthur AndersenPresent
Board Member Nitrase TherapeuticsPresent
Board Member P33 ChicagoPresent
Board Member Nitrome Biosciences, Inc.Present
Board Member AmbAgonPresent
Board Member Enthera PharmaceuticalsPresent
Board Member ReAx BiotechnologiesPresent
Member Board of Regents Ecokargha, Bihar Development TrustPresent
Member Board of Regents Markkula Center for Applied EthicsPresent
Board Member Newron Pharmaceuticals SpAPresent
Board Member Aligos TherapeuticsPresent
Venture Partner Arthur AndersenPresent
Sign in with Google →
Sign in with Google →